Surfactant protein (SP)-D gene targeted (SP-DϪ
Surfactant protein (SP)-D is a member of the collectin subgroup of the mammalian C-type lectins that includes SP-A, mannosebinding protein, and conglutinin (1, 2) . The collectins mediate innate host defense against various bacterial and viral pathogens. The collectins form multimeric structures resembling C1q (the first component of the complement cascade), consisting of multimeric collagenous aminoterminal domains and globular carboxyterminal, carbohydrate-binding domains (2) . The C-type lectins bind carbohydrate surfaces of many microorganisms mediating phagocytosis and killing by phagocytic cells (3) .
In the lung, SP-D is produced primarily by alveolar Type II cells and nonciliated bronchiolar cells (4) . SP-D binds to alveolar macrophages (5) , binds many species of Gram-negative bacteria, including Pseudomonas aeruginosa, Klebsiella pneumoniae, and Haemophilus influenzae (6) , and binds certain Gram-positive organisms, including strains of Streptococcus pneumonia and Staphylococcus aureus (7) . SP-D inhibits the infectivity of influenza A virus (IAV), induces aggregation of IAV particles, and enhances binding and uptake of IAV by neutrophils (8, 9) . In vivo, SP-D-deficient mice (SP-D Ϫ/Ϫ ) show decreased viral clearance and enhanced inflammation in the lung after challenge with ( Received in original form March 25, 2003 and in revised form March 5, 2004) IAV (10) . SP-D also interacts with other viruses; bovine SP-D inhibits the infectivity of rotaviruses through calcium-dependent attachment to the major viral envelope glycoprotein (11) .
Respiratory syncytial virus (RSV) produces an upper respiratory tract disease that may progress to acute bronchiolitis or interstitial pneumonia. Approximately 1 in 100 children infected with RSV will require hospitalization (12) ; as many as 11% of hospitalized infants may require intensive care (13) . Children with respiratory failure from RSV bronchiolitis have decreased concentrations of SP-A and SP-D in bronchoalveolar lavage (BAL) fluid (BALF) (14) . Conditions predisposing to severe RSV disease include prematurity, bronchopulmonary dysplasia, and cystic fibrosis, conditions that may also be associated with decreased SP-D in the lung (15, 16) . RSV is an enveloped, negative-strand RNA virus with a genome that encodes at least 10 viral proteins with 2 major surface glycoproteins (G and F), which are incorporated in the virus envelope. The G protein is responsible for attachment of the virus to the host cell surface (17) , whereas the F protein is responsible for penetration of the virus into the host cells and subsequent cell-to-cell spread (18) .
Specific as well as nonspecific immune mechanisms take part in RSV immunity and probably also RSV pathogenesis. The specific immune response includes cytotoxic T cells and antibody production. Nonspecific immune responses include natural killer cells, macrophages, neutrophils, eosinophils, and basophils (19) . Cytotoxic T lymphocytes are thought to mediate clearance of virus by direct cytolysis of virus-infected cells (20) . Defects in neutrophil and monocyte, chemotactic, oxidative, and bacterial killing functions have been documented in IAV infection (21, 22) . In vitro, neutrophil dysfunction resulting from IAV exposure is diminished when the virus is preincubated with SP-D (8) .
In spite of considerable in vitro evidence that SP-D is involved in host defense, its role in vivo has only recently been demonstrated. SP-D Ϫ/Ϫ mice have increased inflammatory responses in the lung with bacterial infection and after IAV infection (10, 23) . Although clearance of most bacteria from the lung was maintained, SP-D Ϫ/Ϫ mice were highly susceptible to IAV infection, clearing the virus poorly. In the present study, SP-D Ϫ/Ϫ mice were infected intratracheally with RSV. Viral clearance, lung inflammation, phagocytosis, and oxygen radical production by phagocytic cells were compared in SP-D Ϫ/Ϫ mice and SP-D ϩ/ϩ mice, in vivo.
Materials and Methods

Animal Husbandry
SP-D Ϫ/Ϫ mice were generated by targeted gene inactivation as previously described (23) . NIH Swiss Black ϩ/ϩ and SP-D Ϫ/Ϫ mice were studied. Animals were housed using barrier containment and studied under Institutional Animal Care and Use Committee-approved protocols in the animal facility of the Children's Hospital Research Foundation, Cincinnati. Routine viral serology of sentinel mice was used to assure viral free containment. Male and female mice of ‫ف‬ 20-25 g (56-63 d old) were used.
Preparation of RSV
HEp-2 cells were maintained in Eagle's minimal essential media (EMEM) supplemented with glutamine, amphotericin, streptomycin, penicillin G, and 10% low immunoglobulin fetal bovine serum (10% EMEM). The A2 strain of RSV was plaque-purified three times under agarose. The third plaque was inoculated into a subconfluent HEp-2 cell monolayer. After adsorption for 1 h at room temperature 10% EMEM was added and the infection was allowed to proceed for 3 d at 37ЊC until the entire monolayer showed cytopathic effects. The contents of the flask were resuspended and distributed in 1-ml aliquots, quick-frozen with alcohol/dry ice, and stored at Ϫ80Њ. Virus was derived from this master stock by infecting subconfluent HEp-2 monolayers at multiplicity of infection of 0.1, and harvesting the monolayer when it appeared to be completely infected. The cells and media (50 ml) were sonicated (Ultrasonic homogenizer; Cole-Parmer Instrument Co., Chicago, IL) on ice with eight 1-s bursts using output of 50. The suspension was clarified by centrifugation at 1,800 RPM for 10 min. The supernatant was frozen and stored at Ϫ80ЊC and thawed rapidly at 37ЊC for use.
Viral Infection
Administration of RSV into the respiratory tract of the mice was performed by intratracheal inoculation of 10 7 plaque-forming units (pfu) diluted in 10% EMEM. Intratracheal inoculation as previously described (23) was used to deliver RSV. Controls received sterile 10% diluent. After inoculation, mice recovered and were returned to water and food ad libitum.
Clearance of RSV
Quantitative RSV cultures were performed 3 and 5 d on lung homogenates after inoculation of the mice with RSV. The entire lung was removed, homogenized in 2 ml of sterile 10% EMEM, weighed, and placed on ice. HEp-2 monolayers, 80% confluent in Costar 12-well plates, were used for plaque assay. Lung tissues were clarified, serially diluted in 10% EMEM, plated on HEp-2 monolayer (50 l), adsorbed for 1 h, and 0.75% methylcellulose in 10% EMEM added to each well. After 5 d at 37ЊC the monolayers were fixed with 10% formalin phosphate, stained with hematoxylin-eosin, and viral plaques counted under a dissecting microscope. The resulting titer was divided by the lung weight and reported as pfu/gram of lung.
BAL
Lung cells were recovered by BAL. Animals were killed as described for viral clearance and lungs were lavaged three times with 1 ml of sterile phosphate-buffered saline (PBS). The fluid was centrifuged at 2,000 RPM for 10 min, resuspended in 600 l of PBS, and total cells stained with trypan blue and counted under light microscopy. Differential cell counts were performed on cytospin preparations stained with Diff-Quick (Scientific Products, McGaw Park, IN).
Pathology
Lungs were inflated via a tracheal cannula at 20 cm of pressure with 4% paraformaldehyde and removed en-block from the thorax. Lungs were dehydrated and embedded in paraffin. Each lobe of the lung was bisected and four sections obtained in a caudal to cranial orientation from the cut surface. Tissue sections (5 m) were stained with hematoxylin-eosin. Tissue sections were scored for inflammation by two observers blinded to treatment. The scoring system: 0 ϭ no inflammation, 1 ϭ few monocytes/macrophages, 2 ϭ increased cells, 3 ϭ most alveoli or bronchioles with inflammatory cells, 4 ϭ consolidation of alveoli or intraluminal inflammatory cells.
Cytokine Production
Lung homogenates were centrifuged at 2,000 RPM and the supernatants stored at Ϫ20ЊC. Tumor necrosis factor-␣ (TNF-␣), interleukin (IL)-1␤, IL-6, macrophage inflammatory protein (MIP)-2, and interferon (IFN)-␥ were quantitated using murine sandwich enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN) according to the manufacturer's directions. All plates were read on a microplate reader (Molecular Devices, Menlo Park, CA) and analyzed with the use of a computer-assisted analysis program (Softmax; Molecular Devices). Only assays having standard curves with a calculated regression line value Ͼ 0.95 were accepted for analysis.
Recombinant Rat SP-D
Recombinant rat SP-D dodecamers were expressed by stably transfected CHO-K1 cells as previously described (24) . Secreted SP-D was isolated by maltosyl-agarose affinity chromatography and gel filtration chromatography. Bound proteins were eluted in HEPES-buffered saline containing 10 mM ethylenediamine tetraacetic acid (EDTA) and stored at Ϫ80ЊC. The protein concentration was estimated using a dye binding assay with bovine serum albumin as standard. The level of endotoxin contamination was quantified using an end-point chromogenic microplate assay (Chromogenix, Milan, Italy) with Escherichia coli 0111:B4 endotoxin as a standard. The endotoxin content of the purified recombinant proteins used for these experiments was Ͻ 2 ng/ml for stock solutions. Biotinylation of recombinant rat SP-D was labeled at primary amino-groups with EZ-link-Sulfo-NHS-LC-Biotin (Pierce, Rockford, IL). Reactions were performed with limited modifications of the manufacturer's recommendation procedure as described below. SP-D was diluted in 10-20 g/ml with PBS, pH 7.4. Sulfo-NHS-Biotin (1 mg/ml) was prepared fresh in distilled water and 10-20 l added to the protein. Reactants were mixed, transferred to a 500-l Slide-A-Lyser cassette (Pierce), incubated for 2 h at room temperature, and then the cassette was dialyzed against PBS for 2 h. Biotinylation was determined by the HABA/Avidin reaction and the biotinylated protein stored at Ϫ80ЊC. The specific activity was ‫ف‬ 50 pmole/g SP-D.
Binding of SP-D to RSV
Vero cells (ATCC, Manassas, VA) were cultured in MEM supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin, and 2 mM L-glutamine at 37ЊC with 5% CO 2 . Cells were infected with RSV at a multiplicity of infectivity (MOI) of 5, incubated for 24 h at 37ЊC, scraped, and washed twice with phenol red-free MEM with 2 mM CaCl 2 . RSV-infected cells were then incubated with 100 ng/ml of biotinylated SP-D, SP-D (100 ng/ml) with 10 mM EDTA, or SP-D (100 ng/ml) with 167 mM maltose for 1 h at 37ЊC. Cells were washed with MEM, incubated with streptavidin R-phycoerythrin for 30 min, washed, and binding assessed using a FACScalibur flow cytometer (BD Bioscience, San Jose, CA). Surface expression of RSV G or F proteins were determined by incubating the RSV-infected vero cells with an anti-RSV protein-G antibody (1:500 dilution) or anti-RSV protein-F antibody (1:500 dilution; Research Diagnostics, Flanders, NJ) for 1 h and staining with 1 g/ml of fluorescein isothiocyanate (FITC)-goat anti-mouse IgA antibody (PharMingen, San Diego, CA). Cells were analyzed by flow cytometry and RSV infectivity determined by the percent increase in mean fluorescence intensity over isotype control. Recombinant vaccinia viruses expressing the attachment (RSV-G) glycoprotein of RSV (VG) and fusion (RSV-F) glycoprotein (VF) were generated as previously described (25) . Vaccinia virus expressing a ␤ galactosidase gene (VSC11) was used as control. Vero cells were infected with vaccinia virus at an MOI of 10 for 24 h, then binding of SP-D was determined as described for RSV-infected cells. Baseline binding of SP-D to control vaccinia without VF or VG was subtracted from binding to vero cells infected with VF or VG and the results reported as fold increase in mean fluorescence intensity over control virus. Binding of SP-D to RSV-infected cells was also determined after competitive inhibition with F and G antibodies.
FITC Labeling of RSV
FITC stock was prepared at 1 mg/ml in 1 mol/L sodium carbonate, pH 8.0. FITC-labeled virus (RSV) was prepared by incubating concentrated virus stocks with FITC (10:1 mixture by volume of virus in PBS with FITC stock) for 1 h, followed by dialysis of the mixture for 18 h against PBS.
Phagocytosis of RSV
To determine if SP-D enhanced phagocytosis of RSV in vitro, alveolar macrophages, peritoneal macrophages, and neutrophils were compared for the ability to phagocytose RSV in the presence and absence of SP-D. Alveolar macrophages were obtained from wild-type mice as describe for BAL cells. Peritoneal macrophages were obtained from wild-type mice by lavaging the peritoneum five times with 5 ml of MEM media. Neutrophils were obtained after injection of the peritoneal cavity with 1 ml of 3% thioglycolate 24 h and again 4 h before peritoneal lavage. Cells were incubated for 2 h with FITC-RSV or FITC-RSV pre-opsonized with SP-D (100 ng/ml) at an MOI of 5. Cells were then washed, extracellular fluorescence quenched with trypan blue (0.02 g/ml), and cells were washed again and resuspended in PBS with 1% paraformaldehyde. Intracellular fluorescence was determined by flow cytometry and reported as percent phagocytosis.
Phagocytosis of RSV by alveolar macrophages in vivo was measured by intratracheally infecting mice with FITC-RSV followed by evaluation of cell-associated fluorescence by flow cytometry. Two hours after infection, BAL macrophages were obtained as described for BAL, extracellular fluorescence quenched with trypan blue, and cells washed three times and resuspended in PBS containing 1% paraformaldehyde. Cellassociated fluorescence was measured on a FACScalibur flow cytometer, 10,000 cells were counted and the results expressed as percent phagocytosis.
Oxygen Radical Production
Oxygen radical production by peritoneal macrophages and neutrophils was assessed after RSV infection in the presence and absence of SP-D, in vitro. Peritoneal macrophages and neutrophils were obtained as described for the phagocytosis assay, incubated with RSV at an MOI of 5 for 24 h, then loaded with 1 mM lucigenen (Sigma, St. Louis, MO) for 5 min. Oxygen radical production from 1 ϫ 10 5 cells was assessed for RSV infected cells, RSVϩPMA (phorbol myristate acetate) (100 ng/ml), RSV ϩ SP-D (10-400 ng/ml), and RSV ϩ SP-D ϩ PMA. SP-D and PMA were added simultaneously and luminescence measured for 30 min on a Berthold model Autolumat LB 953 luminometer (Berthold Technologies, Oak Ridge, IN) and results reported as the total luminescence.
Oxygen radical production by alveolar macrophages was determined 5 d after intratracheal RSV infection of SP-D ϩ/ϩ and SP-D Ϫ/Ϫ mice. Alveolar macrophages were obtained by BAL as described, loaded with 1 m 2,7 dichlorofluorescin diacetate (DCF; Molecular Probes, Eugene, OR) at 37ЊC for 30 min, washed twice with PBS, and intracellular fluorescence measured by flow cytometry and reported as the mean fluorescent intensity for 10,000 events.
Western Blot
Western blot analysis for SP-A was performed on tissue homogenates. Lung tissue was homogenized in PBS (500 l), spun at 500 RPM then the pellet resuspended in 1 ml 10 mM Tris-Cl (pH 7.4), 0.25 M sucrose, 2 mM EDTA, 1 mM PMSF, 10 M leupeptin, and 10 M pepstatin A. The sample was centrifuged at 15,000 RPM for 15 min at 2ЊC and pellet resuspended in the above buffer (without sucrose) and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on 10-27% gradient gels. Proteins were transblotted to PVDF membranes (Bio-Rad, Inc., Hercules, CA) and blocked with 10 mM Tris-Cl (pH 7.4), 0.15 M NaCl, 0.1% Tween-20 (TBS-T) containing 5% bovine serum albumin. SP-A was detected with guinea pig anti-rat SP-A serum (18) and horseradish peroxidase-conjugated secondary antibody (Calbiochem, Inc., San Diego, CA). Membranes were rinsed and developed using enhanced chemiluminescence detection reagents (Amersham, Arlington Heights, IL). Immunoreactive bands were identified by exposing the membranes to XAR film (Kodak, Rochester, NY).
Surfactant Protein D Concentrations
Concentrations of SP-D in lung homogenates were determined with an ELISA. Three and 5 d after infection with RSV, lungs from infected and uninfected wild-type mice were removed and homogenized in 2 ml of PBS. Surfactant protein D concentrations were measured in a double antibody ELISA using rabbit (AB3434; Chemacu, Temecula, CA) and guinea pig anti-SP-D antisera. Each assay plate included a standard curve generated with purified mouse SP-D. All samples were run in duplicate and the concentrations of the samples were calculated by graphing absorbance versus concentrations of controls.
Statistical Methods
Lung viral titers, BAL total cells, cytokines, phagocytosis, and oxygen radical production were compared using ANOVA and Student's t test.
Lung
Results
Pulmonary Pathology after RSV Administration
Intratracheal administration of RSV (10 7 (Table 1) . SP-D Ϫ/Ϫ mice inoculated with sterile media had baseline inflammation and emphysema as previously described (26) . 
Cytokine Levels in Lung Homogenates
Three and five days after RSV infection, proinflammatory cytokines TNF-␣, IL-1␤, IL-6, and MIP-2 were significantly increased 
SP-D Bound RSV Glycoproteins
The heavily glycosylated F and G proteins of RSV provide a target for binding of SP-D. SP-D bound to RSV-, vaccinia F-, and vaccinia G-infected Vero cells (Table 2). To determine if binding occurs through the carbohydrate recognition domain (CRD) of SP-D interacting with carbohydrate moieties on the
SP-D Enhanced Phagocytosis of RSV
Phagocytosis of FITC-RSV in vitro by alveolar macrophages, peritoneal macrophages, and neutrophils and in vivo by alveolar (Figure 4) . These results suggest that SP-D enhanced phagocytosis of RSV is specific for alveolar macrophages and neutrophils.
SP-D Enhanced Oxygen Radical Production with RSV Infection
Lucigenin was used to evaluate extracellular production of oxygen radicals (27) after RSV infection of peritoneal macrophages and neutrophils in vitro. Oxygen radical production was similar for peritoneal macrophages and neutrophils infected with RSV in the presence or absence of SP-D ( Figure 5 ). Peritoneal macrophages and neutrophils infected with RSV generated less oxygen radicals after PMA stimulation compared with uninfected cells, and this inhibition was reversed when cells were infected with RSV in the presence of SP-D ( Figure 5 ). SP-D in concentrations of 10-400 ng/ml equally reversed the inhibitory effects of RSV on oxidant production (data not shown). SP-D did not directly affect oxygen radical productions from unstimulated or PMAstimulated macrophages or neutrophils (data not shown). The lucigenin assay requires large numbers of cells, which is difficult for in vivo analysis of BAL cells. To evaluate oxygen radical production in vivo by flow cytometry, 2,7 dichlorofluorescin (DCF), which diffuses into cells and becomes fluorescent when exposed to oxygen radical, was used to evaluate intracellular production of oxygen radicals after RSV infection. Alveolar macrophages from RSV-infected SP-D ϩ/ϩ and SP-D Ϫ/Ϫ mice generated less oxygen radicals compared with uninfected mice, and the reduction in oxygen radical production was greater for alveolar macrophages from SP-D SP-D enhanced oxygen radical production by phagocytic cells infected with RSV. RSV inhibits the ability of macrophages and neutrophils to generate oxygen radicals (31, 32) . Uninfected macrophages from SP-D ϩ/ϩ and SP-D Ϫ/Ϫ generated similar amounts of oxygen radicals, in contrast to previous published results in which the macrophages from the SP-D Ϫ/Ϫ mice generated greater oxygen radicals (28, 33) . This difference is believed to be due to the breeding of the strain of mice (Black Swiss) over several years, consistent with findings described by Hickman and colleagues (34) that the phenotype of mice may change over several generations of breeding. In the current study, macrophages and neutrophils infected with RSV generated less oxygen radicals after PMA stimulation compared with PMA stimulation of uninfected cells. In the presence of SP-D, oxygen radical production by PMA-stimulated phagocytic cells was similar to that of uninfected cells, demonstrating that SP-D can reverse the inhibitory effects of RSV on oxidant production. Consistent with this finding, SP-D enhanced neutrophil respiratory burst responses to IAV in vitro (8) . Because SP-D was added to the cells simultaneously with RSV, SP-D may bind and agglutinate the virus, enhancing uptake by the phagocytic cells resulting in enhanced oxygen radical production. However, SP-D selectively reversed the inhibitory effects of RSV on PMA-stimulated phagocytic cells, suggesting a direct effect on cells of SP-D on oxidant production.
Oxidant production by alveolar macrophages was reduced in SP-D Ϫ/Ϫ mice after RSV infection. Whereas previous studies demonstrated increased external release of oxygen radicals by uninfected SP-D Ϫ/Ϫ alveolar macrophages, the current study used an assay with DCF, which measures intracellular oxygen radical production. RSV is known to inhibit the respiratory burst of macrophage and neutrophils, which may contribute, in part, to increased susceptibility of the host to secondary bacterial infection. In vivo, alveolar macrophages from wild-type and SP-D Ϫ/Ϫ mice generated less oxygen radicals after RSV infection; however, the impairment was greater in the absence of SP-D. These findings demonstrate that SP-D plays an important role in regulating macrophage oxygen radical production after viral infection.
After RSV infection, markers of inflammation, including inflammatory cells and cytokines, were increased in the lungs of SP-D Ϫ/Ϫ mice. SP-D Ϫ/Ϫ mice mount an immune response to RSV infection; however, the response is greatly increased compared with wild-type controls. Increased cytokine production may reflect increased cells in BALF after viral infection. Uninfected SP-D Ϫ/Ϫ mice have increased numbers of alveolar macrophages in the lung; however, proinflammatory cytokine concentrations are not increased (33) . Increased TNF-␣, IL-1␤, IL-6, and IFN-␥ levels were demonstrated after IAV infection in mice wherein lymphocytic and mononuclear infiltrates predominate (35) . Lung cytokine responses to IAV were similar to those observed with RSV infection in SP-D Ϫ/Ϫ mice; however, in the absence of SP-D the neutrophilic infiltrates predominated in response to RSV. SP-D concentrations in the lung increased after RSV infection. Although the mechanism of this observed increase is unknown, changes in SP-D synthesis or degradation may alter SP-D levels in the lung during viral infection. In previous studies, SP-D levels increased in the lungs of mice after IAV infection (10) . SP-D levels were reduced in BALF from children with respiratory failure caused by viral infection (14, 36) , suggesting that SP-D concentrations in the lung may vary during the course of viral infection. SP-D levels may increase in the lung early after viral infection to enhance uptake and killing by phagocytic cells. Alternatively, if viral clearance is impaired, resulting in lung inflammation, SP-D levels may decrease due to impaired production or enhanced uptake.
In summary, RSV clearance from the lung was impaired in SP-D Ϫ/Ϫ mice and lung inflammation was more severe in SP-D Ϫ/Ϫ mice. SP-D directly binds RSV, which may play a role in phagocytic clearance of RSV. In the absence of SP-D, oxidant production by alveolar macrophages was reduced after infection, suggesting that SP-D enhances killing of RSV and may protect phagocytic cells from the inhibitory effects of RSV on oxidant production. Because the airway is the usual portal of entry for RSV and other respiratory pathogens, the local production of SP-D is likely to play a role in innate defense responses to inhaled viruses.
